HCV genotypes in chronic hepatitis C and response to interferon.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  The Lancet

• Publication date

  1992-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0140-6736(92)91311-UPMID 1351216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

  1992cited by this paper
• Severity of liver disease with different hepatitis C viral clones

  1991cited by this paper
• Severity of liver disease with different hepatitis C viral clones.

  1991cited by this paper
• Suppression of hepatitis C virus RNA by interferon-α

  1990cited by this paper
• Suppression of hepatitis C virus RNA by interferon-alpha.

  1990cited by this paper

• HCV: The Journey from Discovery to a Cure: Volume II

  2019cites this paper
• The Evolution of Clinical Trials for Hepatitis C

  2019cites this paper
• Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study

  2018cites this paper
• Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals

  2016cites this paper
• COMPARISON OF TWO GENOTYPING METHODS OF HCV-RT-PCR AND DIRECT SEQUENCING

  2016cites this paper
• RESPONSE FACTORS TO PEGYLATED INTERFERON-ALFA/RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 1B

  2014cites this paper
• Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: performance of phylogenetic analysis of the NS5B, E1, and 5'UTR regions in genotyping efficiency.

  2014cites this paper
• Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples.

  2013cites this paper
• The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis

  2012cites this paper
• Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture

  2012cites this paper
• Evolução das quasiespécies da proteína NS5A do vírus da hepatite C genótipo 3a

  2012cites this paper
• The Era of Direct-Acting Antivirals: The Evolving Role of Interferon and Ribavirin for the Treatment of Chronic Hepatitis C

  2012cites this paper
• Pathophysiology and Treatment of Hepatitis C

  2012cites this paper
• Evaluation of Interleukin-8 in Hepatitis C Virus Infection: Relation to Combined peg-interferon Ribavirin Response and Genotype 4

  2011cites this paper
• Autoimmune hepatitis : a clinical study

  2011cites this paper
• mixed cryoglobulinemia Low-grade malignant lymphoma, hepatitis C virus infection, and

  2011cites this paper
• CONTINUING MEDICAL EDUCATION Viral Hepatitis

  2011cites this paper
• Hepatitis C virus: How genetic variability affects pathobiology of disease

  2011cites this paper
• A Novel and Simple Method for HCV Genotyping

  2011cites this paper
• Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan

  2011cites this paper
• Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan Koji YokoyamaMasaharu TakahashiTsutomu NishizawaShigeo Nagashima • Suljid JirintaiShigeru YotsumotoHiroaki OkamotoMariko Y. Momoi

  2011cites this paper
• Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients

  2011cites this paper
• Study of Nitric Oxide in Patients with Chronic Hepatitis C Genotype 4: Relationship to Viremia and Response to Antiviral Therapy

  2010cites this paper
• Distribution of hepatitis C virus genotypes, hepatic steatosis and their correlation with clinical and virological factors in Pakistan

  2010cites this paper
• Prevalence of hepatitis C virus (HCV) genotypes in Balochistan

  2009cites this paper
• study of interferon-β and interferon-α combination therapy for patients its efficacy for hepatic function

  2009cites this paper
• HEPATITIS C VIRUS GENOTYPE DISTRIBUTION IN SHIRAZ, SOUTHERN IRAN

  2009cites this paper
• A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients

  2009cites this paper
• The etiological agent of most cases of post-transfusion hepatitis and a variable proportion of sporadic non-A, non-B hepatitis was discovered in 1989, by recombinant cDNA immunoscreening of serum from a chimpanzee chronicaIIy infected with a conta-

  2009cites this paper
• The relationship of histology to genotype in chronic HCV infection.

  2008cites this paper
• Pathomorphological characteristics and pathogenesis of viral hepatitis

  2008cites this paper
• Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results.

  2008cites this paper
• Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.

  2008cites this paper
• Secondary structure of the hepatitis C virus 5' untranslated region and efficacy of interferon therapy for chronic hepatitis C.

  2008cites this paper
• Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections

  2008cites this paper
• Predictive factors in the response to interferon therapy in chronic hepatitis C.

  2008cites this paper
• Prevalence of Genotype 3a Hepatitis C Virus (HCV) In the Infected Population of Lahore, Pakistan

  2008cites this paper
• Recombinant interferon-alpha-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study.

  2008cites this paper
• Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype.

  2008cites this paper
• [Novel formulations of a liver protection drug glycyrrhizin].

  2007cites this paper
• Efficacy and anticarcinogenic activity of interferon for hepatitis C virus‐related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2

  2007cites this paper
• An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.

  2007cites this paper
• Hepatitis C Virus RNAand AntiN 14 Antibody Levels during Interferon Alpha Therapy for Chronic Hepatitis C

  2007cites this paper
• Efficacy of Interferon Treatment for Chronic Hepatitis C Predicted by Feature Subset Selection and Support Vector Machine

  2007cites this paper
• Heterogeneity of HC V genotypes in France 1065 Table 3 . Genotype classification of HCV isolates used in the present study

  2007cites this paper
• Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon a

  2006cites this paper
• Treatment of hepatitis C virus infection in intravenous drug users

  2006cites this paper
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA‐A2+ HCV‐Infected Patients

  2006cites this paper
• National Centre in HIV Epidemiology and Clinical Research

  2006cites this paper
• Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study

  2006cites this paper
• Depressivität bei Patienten mit chronischer Hepatitis C vor und während der Behandlung mit Alpha-Interferon und Ribavirin

  2005cites this paper
• Interferon Therapy in Hemodialysis Patients with Chronic Hepatitis C: Study of Tolerance, Efficacy and Post-Transplantation Course

  2005cites this paper
• Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C.

  2005cites this paper
• Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C

  2005cites this paper
• Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China

  2005cites this paper
• Selection of hepatitis C virus quasispecies during interferon treatment

  2005cites this paper
• Nephrology Dialysis Transplantation Hepatitis C virus genotypes in chronic dialysis patients

  2005cites this paper
• Treatment of Chronic Hepatitis C with Interferon Alone or Combined with Ribavirin in Japan

  2005cites this paper
• Evaluation of complete genome sequences and sequences of individual gene products for the classification of hepatitis C viruses

  2005cites this paper
• Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN‐resistant cases with hepatocyte steatosis

  2005cites this paper
• Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival

  2005cites this paper
• Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

  2005cites this paper
• Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-related chronic liver disease.

  2005cites this paper
• Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C.

  2005cites this paper
• NephrologyDialysis Transplantation Hepatitis C virus genotype in anti-HCV-positive hemodialysed patients

  2005cites this paper
• Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.

  2004cites this paper
• Hepatitis C Virus Infection and Risk of Hepatocellular Carcinoma Among Japanese: Possible Role of Type lb (II) Infection

  2004cites this paper
• Effects of ribavirin combined with interferon‐α2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads

  2004cites this paper
• Clinical Usefulness of a New Hepatitis C Virus RNA Extraction Method Using Specific Capture Probe and Magnetic Particle in Hemodialysis Patients

  2004cites this paper
• Combination therapy with interferon alpha and beta to chronic hepatitis C.

  2003cites this paper
• Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon

  2003cites this paper
• Efficacy of interferon-alpha treatment in Japanese children with chronic hepatitis C.

  2003cites this paper
• Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.

  2003cites this paper
• Long-term prognosis of the chronic hepatitis C patients treated with interferon

  2003cites this paper
• Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection.

  2003cites this paper
• Liver Disease in Alexandria, Egypt

  2003cites this paper
• The Prevalence of Hepatitis B and C Virus Infections among Liver Cirrhosis Patients at the Korle-Bu Teaching Hospital, Accra-Ghana

  2003cites this paper
• Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy

  2003cites this paper
• Efficacy of interferon‐α treatment in Japanese children with chronic hepatitis C

  2003cites this paper
• Sequence Analysis of PePHD Within HCV E2 Region and Correlation With Resistance of Interferon Therapy in Japanese Patients Infected With HCV Genotypes 2a and 2b

  2003cites this paper
• Macroglobulinemia and membranoproliferative glomerulonephritis in a hepatitis C virus-positive patient.

  2003cites this paper
• Effective interferon therapy for chronic hepatitis C patients with low viral loads.

  2003cites this paper
• Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon.

  2003cites this paper
• Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China.

  2003cites this paper
• Mutations of the core gene sequence of HCV from patients with hepatocellular carcinoma in China

  2003cites this paper
• Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease.

  2002cites this paper
• Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment.

  2002cites this paper
• Fluctuation of serum HCV‐RNA levels in untreated blood donors with chronic hepatitis C virus infection

  2002cites this paper
• The efficacy of a herbal medicine (Mao-to) in combination with intravenous natural interferon-beta for patients with chronic hepatitis C, genotype 1b and high viral load: a pilot study.

  2002cites this paper
• Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie Charité, Campus Virchow-Klinikum (Direktor: Professor Dr. Bertram Wiedenmann)

  2002cites this paper
• Dynamics of Hepatitis C Virus Monitored by Real-Time Quantitative Polymerase Chain Reaction During First 2 Weeks of IFN-β Treatment Are Predictive of Long-Term Therapeutic Response

  2002cites this paper
• HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.

  2002cites this paper
• Prospective study of a high-intensity interferon-alpha regimen for chronic hepatitis C virus genotype 1b infection.

  2002cites this paper
• Relationship between 24-hour rhythm in antiviral effect of interferon-beta and interferon-alpha/beta receptor expression in mice.

  2002cites this paper
• Accurate Prediction of Response to Interferon Therapy by Repeated Measurement of Hepatitis C Virus Core Protein in Patients with Chronic Hepatitis C

  2002cites this paper
• Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.

  2002cites this paper
• Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-α treatment

  2002cites this paper
• Relationship Between 24-Hour Rhythm in Antiviral Effect of Interferon-β and Interferon-α/β Receptor Expression in Mice

  2002cites this paper
• Review Treatment of chronic viral hepatitis

  2001cites this paper
• Virology of hepatitis C virus

  2001cites this paper